These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 36529704)

  • 101. What is the standard regimen for patients with acute promyelocytic leukemia?
    Lo-Coco F; Cicconi L
    Curr Hematol Malig Rep; 2014 Jun; 9(2):138-43. PubMed ID: 24729066
    [TBL] [Abstract][Full Text] [Related]  

  • 102. Granulocyte colony-stimulating factor potentiates differentiation induction by all-trans retinoic acid and arsenic trioxide and enhances arsenic uptake in the acute promyelocytic leukemia cell line HT93A.
    Iriyama N; Yuan B; Hatta Y; Horikoshi A; Yoshino Y; Toyoda H; Aizawa S; Takeuchi J
    Oncol Rep; 2012 Nov; 28(5):1875-82. PubMed ID: 22940758
    [TBL] [Abstract][Full Text] [Related]  

  • 103. First experience of the AML-Berlin-Frankfurt-Münster group in pediatric patients with standard-risk acute promyelocytic leukemia treated with arsenic trioxide and all-trans retinoid acid.
    Creutzig U; Dworzak MN; Bochennek K; Faber J; Flotho C; Graf N; Kontny U; Rossig C; Schmid I; von Stackelberg A; Mueller JE; von Neuhoff C; Reinhardt D; von Neuhoff N
    Pediatr Blood Cancer; 2017 Aug; 64(8):. PubMed ID: 28111878
    [TBL] [Abstract][Full Text] [Related]  

  • 104. Management of relapse in acute promyelocytic leukaemia treated with up-front arsenic trioxide-based regimens.
    Fouzia NA; Sharma V; Ganesan S; Palani HK; Balasundaram N; David S; Kulkarni UP; Korula A; Devasia AJ; Nair SC; Janet NB; Abraham A; Mani T; Lakshmanan J; Balasubramanian P; George B; Mathews V
    Br J Haematol; 2021 Jan; 192(2):292-299. PubMed ID: 33216980
    [TBL] [Abstract][Full Text] [Related]  

  • 105. Bayesian network meta-analysis comparing five contemporary treatment strategies for newly diagnosed acute promyelocytic leukaemia.
    Wu F; Wu D; Ren Y; Duan C; Chen S; Xu A
    Oncotarget; 2016 Jul; 7(30):47319-47331. PubMed ID: 27322078
    [TBL] [Abstract][Full Text] [Related]  

  • 106. Long-term outcome of children with acute promyelocytic leukemia: a randomized study of oral versus intravenous arsenic by SCCLG-APL group.
    Huang DP; Yang LC; Chen YQ; Wan WQ; Zhou DH; Mai HR; Li WL; Yang LH; Lan HK; Chen HQ; Guo BY; Zhen ZJ; Liu RY; Chen GH; Feng XQ; Liang C; Wang LN; Li Y; Luo JS; Fan Z; Luo XQ; Li B; Tang YL; Zhang XL; Huang LB
    Blood Cancer J; 2023 Dec; 13(1):178. PubMed ID: 38052803
    [TBL] [Abstract][Full Text] [Related]  

  • 107. Improved long-term survival in all Sanz risk patients of newly diagnosed acute promyelocytic leukemia treated with a combination of retinoic acid and arsenic trioxide-based front-line therapy.
    Lou Y; Lu Y; Zhu Z; Ma Y; Suo S; Wang Y; Chen D; Tong H; Qian W; Meng H; Mai W; Yu W; Xu W; Wang L; Mao L; Pei R; Jin J
    Hematol Oncol; 2018 Jun; ():. PubMed ID: 29862538
    [TBL] [Abstract][Full Text] [Related]  

  • 108. Fertility and parenthood in patients with acute promyelocytic leukemia treated with Arsenic Trioxide and All-Trans retinoic acid.
    Singh C; Saini M; Jain A; Lad D; Prakash G; Khadwal A; Naseem S; Malhotra P
    Blood Cancer J; 2024 Jan; 14(1):14. PubMed ID: 38238308
    [No Abstract]   [Full Text] [Related]  

  • 109. Treatment of Pediatric Acute Promyelocytic Leukemia with Retinoic Acid and Arsenic Trioxide along with Chemotherapy.
    Srinivasan S; Dhamne C; Moulik NR; Chichra A; Tembhare P; Patkar N; Subramanian PG; Shetty D; Narula G; Banavali S
    Indian J Pediatr; 2024 Jun; 91(6):564-570. PubMed ID: 37380920
    [TBL] [Abstract][Full Text] [Related]  

  • 110. Additional cytogenetic abnormalities in patients with newly diagnosed acute promyelocytic leukemia predict inferior event-free survival.
    Zeng H; Dong HB; Zhang QG; Zhou M; Zhang Q; Chen LX; Yuan CY; Jiang RR; Liu JW; Ou-Yang J; He J; Chen B
    Cancer Med; 2023 Sep; 12(17):17766-17775. PubMed ID: 37584196
    [TBL] [Abstract][Full Text] [Related]  

  • 111. Treatment outcomes of patients with acute promyelocytic leukaemia between 2000 and 2017, a retrospective, single centre experience.
    Chien N; Varghese C; Green TN; Chan G; Theakston E; Eaddy N; Doocey R; Berkahn L; Hawkins T; Browett PJ; Kalev-Zylinska ML
    Leuk Res; 2020 Apr; 93():106358. PubMed ID: 32380366
    [TBL] [Abstract][Full Text] [Related]  

  • 112. Clinical Indicators of Hepatotoxicity in Newly Diagnosed Acute Promyelocytic Leukemia Patients Undergoing Arsenic Trioxide Treatment.
    Zhang Z; Zhang S; Zhang F; Zhang Q; Wei H; Xiu R; Zhao Y; Sui M
    Biol Trace Elem Res; 2024 Jan; 202(1):122-132. PubMed ID: 37097388
    [TBL] [Abstract][Full Text] [Related]  

  • 113. Leucocytosis during all-trans retinoic acid and arsenic trioxide treatment in acute promyelocytic leukaemia.
    Yanada M
    Br J Haematol; 2024 Nov; 205(5):1672-1673. PubMed ID: 39279289
    [TBL] [Abstract][Full Text] [Related]  

  • 114. Outcomes of Acute Promyelocytic Leukaemia in Paediatric Patients: Insights from a Low-Middle-Income Country.
    Naz S; Ghafoor T; Manzoor R; Hira B; Ahmed S; Arshed A
    J Coll Physicians Surg Pak; 2024 Aug; 34(8):974-980. PubMed ID: 39113519
    [TBL] [Abstract][Full Text] [Related]  

  • 115. Highly Curative Treatment of High-Risk Acute Promyelocytic Leukemia: Induction and Consolidation with ATRA+ATO+anthracyclines and Maintenance with ATRA+RIF.
    Liu D; Tong J; Chen E; Wang L; Xue L; Zhang X; Zhao N; Hu X; Zheng C
    Blood Lymphat Cancer; 2024; 14():63-69. PubMed ID: 39100972
    [TBL] [Abstract][Full Text] [Related]  

  • 116. Therapy-related myeloid neoplasms following curative treatment of acute promyelocytic leukemia: incidence, correlation with therapeutic regimen, and future directions.
    Menon A; Sukhanova M; Gao J; Wolniak K; Fu L; Chen YH; Chen QC; Tariq H
    J Hematop; 2024 Dec; 17(4):201-208. PubMed ID: 39254828
    [TBL] [Abstract][Full Text] [Related]  

  • 117. A Case of Relapsed/Refractory CD56-Positive Acute Promyelocytic Leukemia, in Which Complete Molecular Remission Was Achieved Following Combination Therapy with Venetoclax and Azacitidine.
    Sekiguchi Y; Tsutsumi H; Gomyo A; Kudo M; Maseki N; Iizaki Y; Kawamura M; Kobayashi K; Nitta H; Noguchi M; Wakita S; Yamaguchi H; Kobayashi H
    Gan To Kagaku Ryoho; 2024 Mar; 51(3):291-297. PubMed ID: 38494811
    [TBL] [Abstract][Full Text] [Related]  

  • 118. Evolving Chemotherapy Free Regimens for Acute Promyelocytic Leukemia.
    Kulkarni U; Mathews V
    Front Oncol; 2021; 11():621566. PubMed ID: 33718181
    [TBL] [Abstract][Full Text] [Related]  

  • 119. Acute Promyelocytic Leukemia: Review of Complications Related to All-Trans Retinoic Acid and Arsenic Trioxide Therapy.
    Ghiaur A; Doran C; Gaman MA; Ionescu B; Tatic A; Cirstea M; Stancioaica MC; Hirjan R; Coriu D
    Cancers (Basel); 2024 Mar; 16(6):. PubMed ID: 38539495
    [TBL] [Abstract][Full Text] [Related]  

  • 120. A Life-Threatening Complication During the Fourth Pregnancy Due to Acute Promyelocytic Leukemia: A Case Report.
    Sisnawati IA; Salay K; Fadillah LN; Jazilah I; Mintarjo JA; Billah A; Putra AS; Hersana IDMW; Novita C
    Acta Med Indones; 2024 Jan; 56(1):76-83. PubMed ID: 38561886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.